Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers
Authors:
- 1 October 2009
- journal article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 297 (4) , R1154-R1161
Abstract
The opioid growth factor (OGF) regulates cell proliferation of human cancer cells through the cyclin-dependent kinase inhibitory pathway, with mediation of this action by the OGF receptor (OGFr). The ubiquity of the OGF-OGFr axis in human cancer is unknown. We used 31 human cancer cell lines, representative of more than 90% of neoplasias occurring in humans, and found that OGF and OGFr were detected in the cytoplasm and nucleus by immunohistochemistry. The addition of OGF to cultures depressed cell number up to 41%, whereas naltrexone (NTX) increased cell proliferation by up to 44%, a total of 85% in the modulating capacity for the OGF-OGFr axis. Neutralization of OGF by specific antibodies led to a marked increase in cell number. Knockdown of OGFr by OGFr-siRNA resulted in a significant increase in the number of cells, even in the face of the addition of exogenous OGF. The cultures to which NTX was added and subjected to OGFr-siRNA were similar to those with OGF-siRNA alone. The OGF-OGFr axis, a physiological determinant of cell-proliferative activity, is a ubiquitous feature of human cancer cells. The identification of this native biological system in neoplasia may be important in understanding the pathophysiology of neoplasia, and in designing treatment modalities that utilize the body's own chemistry.Keywords
This publication has 63 references indexed in Scilit:
- Cell cycle, CDKs and cancer: a changing paradigmNature Reviews Cancer, 2009
- The OGF–OGFr Axis Utilizes the p16INK4aand p21WAF1/CIP1Pathways to Restrict Normal Cell ProliferationMolecular Biology of the Cell, 2009
- Alteration of cell-cycle regulation in epithelial ovarian cancerInternational Journal of Gynecological Cancer, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancerMolecular Cancer, 2008
- Antineoplastic activity of taxol against human anaplastic thyroid carcinoma cell lines in vitro and in vivoThe Journal of Clinical Endocrinology & Metabolism, 1996
- β-Endorphin Stimulates Proliferation of Small Cell Lung Carcinoma Cells in Vitro via Nonopioid Binding SitesExperimental Cell Research, 1995
- Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: Establishment, characterization and response to cytotoxic treatmentEuropean Journal of Cancer and Clinical Oncology, 1988
- Natural killer (NK)-resistant human lung cancer cells are lysed by recombinant interleukin-2-activated NK cellsCellular Immunology, 1987
- G-6-PD and PGM Phenotypes of 16 Continuous Human Tumor Cell LinesHuman Heredity, 1971